905
Views
32
CrossRef citations to date
0
Altmetric
Review

Management of hypertension in the elderly patient

Pages 379-389 | Published online: 30 Sep 2009

References

  • WeinbergerMHMillerJZLuftFCGrimCEFinebergNSDefinitions and characteristics of sodium sensitivity and blood pressure resistanceHypertension19868127134
  • De WardenerHEMacGregorGASodium and blood pressureCurr Opin Cardiol20021736036712151870
  • BagrovAYLakattaEGThe dietary sodium-blood pressure plot “stiffens”Hypertension200444222415173129
  • FranklinSSJacobsMJWongNDL’ItalienGJLapuertaPPredominance of isolated systolic hypertension among middle-aged and elderly US hypertensives. Analysis based on National Health and Nutrition Examination Survey (NHANES) IIIHypertension20013786987411244010
  • FranklinSSPioJRWongNDPredictors of new-onset diastolic and systolic hypertension. The Framingham Heart StudyCirculation20051111121112715723980
  • FranklinSSArterial stiffness and hypertension. A two-way streetHypertension20054534935115710783
  • MitchellGFLacourciereYOelletJPDeterminants of elevated blood pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationshipCirculation20031081592159812975261
  • VirmaniRAvolioAPMergnerWJEffect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosisAm J Pathol1991139111911291951629
  • O’RourkeNicholsWWAortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertensionHypertension200545part 265265815699456
  • KojdaGHarrisonDGInteractions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failureCardiovasc Res19994356257110690328
  • StokesGSNitrates as adjunct hypertensive treatmentCurr Hypertens Rep20068606816600161
  • VasanSVPathogenesis of elevated peripheral pulse pressure: some reflections and thinking forwardHypertension200851333618071060
  • StokesGSRyanMCan extended-release isosorbide mononitrate be used as adjunctive therapy for systolic hypertension? An open study employing pulse-wave analysis to determine effects of antihypertensive therapyAm J Geriat Cardiol199761119
  • AmadoPVasconcelosNSantosIArterial hypertension difficult to control in the elderly patient. The significance of the “white coat effect”Rev Port Cardiol19991889790610590654
  • IzzoJLLevyDBlackHRImportance of systolic blood pressure in older AmericansHypertension2000351021102410818056
  • SHEP Cooperative Research GroupPrevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP)JAMA1991265325532642046107
  • StaessenJAThijsLFagardRPredicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension: Systolic Hypertension in Europe Trial InvestigatorsJAMA199928253954610450715
  • The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)JAMA20022882981299712479763
  • AllbuttCSwalesJDSenile plethora or high arterial pressure in elderly persons. Lectures to the Hunterian Society of London. 1895, February 27th, lecture 1Classic Papers in Hypertension: Blood pressure and reninLondon, UKScience Press1987104123
  • De WardenerHThe Kidney: An outline of abnormal structure and functionLondon, UKChurchill1961
  • HymanDJPavlikVNSelf-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicineArch Intern Med20011602281228610927724
  • AmeryABirkenhagerWBrixkoPMortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trialLancet19851134913542861311
  • DahlofBLindholmLHHanssonLMorbidity and mortality in the Swedish Trial in Old Patients with Hypertension (Stop-Hypertension)Lancet1991338128112851682683
  • StaessenJAFagardRThijsLRandomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionLancet19973507577649297994
  • ReidCMRyanPWingLMHBlackHRThe 2nd Australian National Blood Pressure Study (ANBP2)Clinical trials in HypertensionNew York, NYMarcel Dekker2001587604
  • StaessenJAGasowskiJWangJGRisks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trialsLancet2000355920786587210752701
  • MulrowCDLauJCornellJBrandMPharmacotherapy for hypertension in the elderlyCochrane Database Syst Rev19982CD00002810796688
  • BeckettNSPetersRFletcherAEfor the HYVET Study GroupTreatment of hypertension in patients 80 years of age or olderN Engl J Med200835997197418753657
  • GueyffierFBulpittCBoisselJPAntihypertensive drugs in very old people; a subgroup meta-analysis of randomised controlled trialsLancet1999353915579379610459960
  • DahlofBSeverPSPoulterNRPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialLancet200536689590616154016
  • FoodyJMChaudrySIKrumholzHMSystolic hypertension in older persons: complexities in clinical decision makingAm J Geriat Cardiol2005146325330
  • Hippiley-CoxJCouplandCVinogradovaYRobsonJMayMBrindlePDerivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort studyBMJ200733513617615182
  • KrumHSchlaichMWhitbournRCatheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort studyLancet20093731275128119332353
  • BramlagePPittrowDWittchenHUHypertension in overweight and obese primary care patients is highly prevalent and poorly controlledAm J Hypertens2004171090491015485752
  • RedonJCea-CalvolMarenoBIndependent impact of obesity and fat distribution in hypertension prevalence and control in the elderlyJ Hypertens2006261757176418698209
  • CookeKMFrostGWThornellIRStokesGSAlcohol consumption and blood pressure: survey of the relationship at a health screening clinicMed J Aust1982165697070333
  • TownsendMSFulgoniVLIIISternJSLow mineral intake is associated with high systolic blood pressure in the Third and Fourth National Health and Nutrition Examination Surveys. Could we all be rightAm J Hypertens20051826126915752955
  • HeFJMarkanduNDMacGregorGAModest salt reduction lowers blood pressure in isolated systolic hypertension and combined hypertensionHypertension200546667015956111
  • GatesPETanakaHHiattWRSealsDRDietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertensionHypertension200444354115173128
  • WheltonSPChinAXinXHeJEffect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trialsAnn Intern Med200213649350311926784
  • BrennanPPescatelloLSBohannonRWTime spent moving is related to systolic blood pressure among older womenPrev Cardiol2005816016416034219
  • FerrierKEWaddellTKGatzkaCDAerobic exercise training does not modify large-artery compliance in isolated systolic hypertensionHypertension20013822222611509480
  • LondonGSchmiederRCalvoCAsmarRIndapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT StudyAm J Hypertens20061911312116461202
  • DahlofBSeverPSPoulterNRPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialLancet200536689590616154016
  • MesserliFHGrossmanEGoldbourtUAre beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic reviewJAMA1998279190319079634263
  • CarlbergBSamuelssonOLindholmLHAtenolol in hypertension: Is it a wise choiceLancet20043641684168915530629
  • KjeldsenSELylePAKizerJRThe effects of losartan compared to atenolol on stroke in patients with isolate systolic hypertension and left ventricular hypertrophy. The LIFE studyJ Clin Hypertens20057152158
  • LindholmLHCarlbergBSamuelssonOShould beta blockers remain first choice in the treatment of primary hypertension? A meta-analysisLancet20053661545155316257341
  • KhanNMcAlisterFARe-examining the efficacy of β-blockers for the treatment of hypertension: a meta-analysisCMAJ20061741737174216754904
  • WilliamsBLacyPSThomSMThe CAFE Investigators, for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators, CAFE Steering Committee and Writing CommitteeDifferential impact of blood pressure–lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) studyCirculation20061131213122516476843
  • MckenzieISMcEnieryCMDhakamZBrownMJCockcroftJRWilkinsonIBComparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertensionHypertension20095440941319487582
  • MyersMGValdiviesoMKissAUse of automated office blood pressure measurement to reduce the white coat responseJ Hypertens20092728028619155785
  • ManciaGBombelliMFacchetiRLong-term risk of sustained hypertension in white coat or masked hypertensionHypertension20095422623219564548
  • NaschitzJWSlobodinGEliasNRosnerIThe patient with supine hypertension and orthostatic hypotension: a clinical dilemmaPostgrad Med J20068224625316597811
  • Combination Pharmacotherapy and Public Health Research Working GroupCombination pharmacotherapy for cardiovascular diseaseAnn Intern Med200514359359916230726
  • MurrellWNitroglycerine as a remedy for angina pectorisLancet18798080227
  • PaucaALKonNDO’RourkeMFBenefit of nitroglycerin on arterial stiffness is directly due to effects on peripheral arteriesHeart2005911428143215761047
  • StokesGSBarinESGilfillanKLEffects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertensionHypertension20034129730112574098
  • BrosnanMJHamiltonCAGrahamDIrbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone ratsJ Hypertens20022028128611821713
  • SchiffrinELDeng LiYComparison of effects of angiotensin I-converting enzyme inhibition and [beta]-blockade for 2 years on function of small arteries from hypertensive patientsHypertension199525part 26996707721419
  • GhiadoniLMagagnaAVersariDDifferent effect of antihypertensive drugs on conduit artery endothelial functionHypertension2003411281128612719441
  • KiowskiWLinderLNueschREffect of cilazopril on vascular structure and function in essential hypertensionHypertension199627part 23713768698440
  • RizzoniDMuiesanMLPorteriEEffects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophyJ Hypertens1997151972049469796
  • ChapmanNDobsonJDobsonSEffect of spironolactone on blood pressure in subjects with resistant hypertensionHypertension20074983984517309946
  • ZannadFLaneDAShahSBeeversGDLow-dose spironolactone in the management of resistant hypertension: a surveillance studyJ Hypertens20072574775017351364
  • LoganAGPerlikowskiSMMenteAHigh prevalence of unrecognized sleep apnea: implications for cardiac and vascular diseaseJAMA20011922712277
  • GroteLHednerJPeterJHSleep-related breathing disorder is an independent risk factor for uncontrolled hypertensionJ Hypertens20001867968510872551
  • CalhounDANishizakaMKZamanMAHardingSMAldosterone excretion among subjects with resistant hypertension and symptoms of sleep apneaChest200412511211714718429